source
- Formation Bio appoints veteran biotech leader Michael Ehlers as chief scientific officerFormation Bio, an AI-focused biotech, announced the hiring of Michael Ehlers, M.D., Ph.D., as its chief scientific officer and head of research and development. Ehlers brings a blend of academic a…
- GSK secures FDA approval for lung-cancer drug Jideytro after $10.6 billion Nuvalent acquisitionGSK received FDA clearance for Jideytro, a therapy for patients with metastatic non‑small cell lung cancer that have ROS1 gene alterations and have already been treated with another targeted drug.…